Mediwelcome Healthcare Management & Technology Inc. (HKG:2159)

HKG:2159 Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	138.54	99.32	71.66	80.35	138.57	165.33
Trading Asset Securities	-	-	-	-	15.45	9.5
Cash & Short-Term Investments	138.54	99.32	71.66	80.35	154.02	174.83
Cash Growth	47.01%	38.60%	-10.82%	-47.83%	-11.90%	66.68%
Accounts Receivable	22.03	29.43	50.39	56.86	76.69	84.25
Other Receivables	13.59	0.91	1.28	16.09	1.35	0.44
Receivables	35.62	30.34	51.68	72.96	78.04	84.68
Prepaid Expenses	-	-	-	-	-	0.33
Other Current Assets	26.29	26.46	37.53	27.76	19.2	15.47
Total Current Assets	200.46	156.12	160.86	181.07	251.27	275.32
Property, Plant & Equipment	5.99	8.46	11.54	10.75	15.4	24.43
Long-Term Investments	9.93	15.39	20.65	17.05	16.15	22.57
Goodwill	71.78	-	-	-	-	3.12
Other Intangible Assets	159.06	9.26	-	-	30.56	37.94
Long-Term Deferred Tax Assets	-	-	-	2.18	1.41	0.62
Other Long-Term Assets	0.7	1.26	1.04	3.28	3.04	2.71
Total Assets	447.91	190.49	194.09	214.32	317.83	366.7

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Accounts Payable	10.38	13.15	37.6	32.3	34.02	27.41
Accrued Expenses	2.64	1.87	8.99	9.43	17.43	12.6
Short-Term Debt	60.59	47.62	39.03	21.51	9.09	-
Current Portion of Leases	4.06	4.33	4.94	7.6	8.91	9.53
Current Income Taxes Payable	2.43	2.97	3.02	1.5	0.28	0.1
Current Unearned Revenue	31.61	12.11	23.15	18.7	37.05	5.8
Other Current Liabilities	136.11	0.54	0.32	1.24	1.3	1.84
Total Current Liabilities	247.81	82.59	117.05	92.27	108.08	57.27
Long-Term Leases	0.47	2.52	3.76	2.02	8.49	15.66
Long-Term Deferred Tax Liabilities	19.41	-	-	0.06	0.41	0.29
Total Liabilities	267.69	85.11	120.81	94.35	116.97	73.21

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Common Stock	0	0	0	0	0	0
Additional Paid-In Capital	132.26	132.26	98.6	98.6	98.6	98.6
Retained Earnings	-102.98	-120.88	-130.87	-86.4	6.84	86.68
Comprehensive Income & Other	100.6	99.88	103.41	103.92	89.58	97.83
Total Common Equity	129.87	111.25	71.14	116.13	195.02	283.11
Minority Interest	50.34	-5.87	2.14	3.84	5.84	10.38
Shareholders' Equity	180.22	105.38	73.28	119.97	200.86	293.49
Total Liabilities & Equity	447.91	190.49	194.09	214.32	317.83	366.7

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Total Debt	65.12	54.47	47.73	31.13	26.48	25.18
Net Cash (Debt)	73.43	44.85	23.93	49.22	127.54	149.65
Net Cash Growth	63.69%	87.42%	-51.39%	-61.41%	-14.77%	88.32%
Net Cash Per Share	0.30	0.20	0.12	0.26	0.69	0.82
Filing Date Shares Outstanding	280	280	200	200	200	200
Total Common Shares Outstanding	280	280	200	200	200	200
Working Capital	-47.35	73.53	43.81	88.8	143.19	218.05
Book Value Per Share	0.46	0.40	0.36	0.58	0.98	1.42
Tangible Book Value	-100.97	101.99	71.14	116.13	164.46	242.05
Tangible Book Value Per Share	-0.36	0.36	0.36	0.58	0.82	1.21
Machinery	-	19.76	21.45	21.52	22.41	21
Leasehold Improvements	-	3.58	4.61	4.61	4.61	4.61

Data Source: S&P Global Market Intelligence Last updated: Jun 30, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Aug 22, 2026

Data Sources Report a data error